New Monoclonal Authorized to Prevent COVID in Immunocompromised People

(MedPage Today) -- The FDA issued an emergency use authorization (EUA) for pemivibart (Pemgarda) as COVID-19 pre-exposure prophylaxis in immunocompromised individuals who are unlikely to mount a sufficient immune response following vaccination...
Source: MedPage Today Public Health - Category: American Health Source Type: news